Z-1194-2019 Class II Terminated

Recalled by Roche Diagnostics Corporation — Indianapolis, IN

FDA device recall Z-1194-2019 was initiated by Roche Diagnostics Corporation on Mar 18, 2019 and is designated Class II. Reason for recall: The reagent lot is exhibiting calibration failures, QC imprecision, and elevated QC recovery due to elevated pH level causing higher absorbance values. The recall status is terminated (terminated Aug 28, 2020). Affected quantity: 774.

Recall details

Product Type
Devices
Report Date
Apr 24, 2019
Initiation Date
Mar 18, 2019
Termination Date
Aug 28, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
774

Product description

Albumin BCP Product Usage: ALBP is an in vitro test used for the quantitative determination of albumin in human serum and plasma on Roche/Hitachi cobas c systems.

Reason for recall

The reagent lot is exhibiting calibration failures, QC imprecision, and elevated QC recovery due to elevated pH level causing higher absorbance values.

Distribution pattern

US Nationwide distribution in the states of: GA, IL, KY, MI, and TX.

Code information

Catalog Number 05975573190 Lot Number 35651401

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1194-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1194-2019. Report a data issue: hello@regdatalab.com.